Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2020, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Palbociclib Capsules, 75 mg, 100 mg, and 125 mg.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 09, 2020, titled "Alembic Pharmaceuticals receives USFDA Tentative Approval for Palbociclib Capsules, 75 mg, 100 mg, and 125 mg.".